(Q37784771)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

title

PET/CT in cancer research: from preclinical to clinical applications (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Silvana Del Vecchio

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Rosa Fonti

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

Francesca Iommelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

author name string

A Zannetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

L M Pizzuti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

A Lettieri

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

publication date

1 July 2010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

Contrast Media & Molecular Imaging

13 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

volume

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

page(s)

190-200

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

cites work

The Hallmarks of Cancer

1 reference

7 January 2021

Molecular-genetic imaging based on reporter gene expression

1 reference

7 January 2021

Imaging of cell proliferation: status and prospects

1 reference

7 January 2021

FLT: measuring tumor cell proliferation in vivo with positron emission tomography and 3'-deoxy-3'-[18F]fluorothymidine

1 reference

7 January 2021

[18F]FLT PET for diagnosis and staging of thoracic tumours

1 reference

7 January 2021

Clinical relevance of imaging proliferative activity in lung nodules

1 reference

7 January 2021

Evaluation of thoracic tumors with 18F-fluorothymidine and 18F-fluorodeoxyglucose-positron emission tomography

1 reference

7 January 2021

Potential impact of [ 18 F]3'-deoxy-3'-fluorothymidine versus [ 18 F]fluoro-2-deoxy-d-glucose in positron emission tomography for colorectal cancer

1 reference

7 January 2021

Comparison of methodologies for the in vivo assessment of 18FLT utilisation in colorectal cancer

1 reference

7 January 2021

[18F]3'-deoxy-3'-fluorothymidine PET for the diagnosis and grading of brain tumors

1 reference

7 January 2021

Quantification of cellular proliferation in tumor and normal tissues of patients with breast cancer by [18F]fluorothymidine-positron emission tomography imaging: evaluation of analytical methods

1 reference

7 January 2021

Early detection of tumor response to chemotherapy by 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography: the effect of cisplatin on a fibrosarcoma tumor model in vivo

1 reference

7 January 2021

Redistribution of nucleoside transporters to the cell membrane provides a novel approach for imaging thymidylate synthase inhibition by positron emission tomography

1 reference

7 January 2021

Early assessment of therapy response in malignant lymphoma with the thymidine analogue [18F]FLT

1 reference

7 January 2021

Imaging proliferation to monitor early response of lymphoma to cytotoxic treatment

1 reference

7 January 2021

In vivo biological activity of the histone deacetylase inhibitor LAQ824 is detectable with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

7 January 2021

Early detection of erlotinib treatment response in NSCLC by 3'-deoxy-3'-[F]-fluoro-L-thymidine ([F]FLT) positron emission tomography (PET).

1 reference

7 January 2021

Noninvasive imaging of cell proliferation following mitogenic extracellular kinase inhibition by PD0325901.

1 reference

7 January 2021

Predicting treatment response of malignant gliomas to bevacizumab and irinotecan by imaging proliferation with [18F] fluorothymidine positron emission tomography: a pilot study

1 reference

7 January 2021

Early Response Assessment Using 3'-Deoxy-3'-[18F]Fluorothymidine-Positron Emission Tomography in High-Grade Non-Hodgkin's Lymphoma

1 reference

7 January 2021

Imaging early changes in proliferation at 1 week post chemotherapy: a pilot study in breast cancer patients with 3'-deoxy-3'-[18F]fluorothymidine positron emission tomography.

1 reference

7 January 2021

PET imaging with [18F]3'-deoxy-3'-fluorothymidine for prediction of response to neoadjuvant treatment in patients with rectal cancer.

1 reference

7 January 2021

Gefitinib--a novel targeted approach to treating cancer

1 reference

7 January 2021

Multimodality imaging of the HER-kinase axis in cancer

1 reference

7 January 2021

Quantitative PET of EGFR expression in xenograft-bearing mice using 64Cu-labeled cetuximab, a chimeric anti-EGFR monoclonal antibody

1 reference

7 January 2021

Disparity between in vivo EGFR expression and 89Zr-labeled cetuximab uptake assessed with PET.

1 reference

7 January 2021

Potential (18)F-labeled biomarkers for epidermal growth factor receptor tyrosine kinase.

1 reference

7 January 2021

Labeled EGFr-TK irreversible inhibitor (ML03): in vitro and in vivo properties, potential as PET biomarker for cancer and feasibility as anticancer drug.

1 reference

7 January 2021

Molecular imaging of EGFR kinase activity in tumors with 124I-labeled small molecular tracer and positron emission tomography.

1 reference

7 January 2021

High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors

1 reference

7 January 2021

Novel carbon-11 labeled 4-dimethylamino-but-2-enoic acid [4-(phenylamino)-quinazoline-6-yl]-amides: potential PET bioprobes for molecular imaging of EGFR-positive tumors

1 reference

7 January 2021

Evaluation of radiolabeled ML04, a putative irreversible inhibitor of epidermal growth factor receptor, as a bioprobe for PET imaging of EGFR-overexpressing tumors

1 reference

7 January 2021

Synthesis of [11C]Iressa as a new potential PET cancer imaging agent for epidermal growth factor receptor tyrosine kinase

1 reference

7 January 2021

Positron emission tomography (PET) imaging with [11C]-labeled erlotinib: a micro-PET study on mice with lung tumor xenografts.

1 reference

7 January 2021

Evaluation of [(18)F]gefitinib as a molecular imaging probe for the assessment of the epidermal growth factor receptor status in malignant tumors.

1 reference

7 January 2021

PET-based biodistribution and radiation dosimetry of epidermal growth factor receptor-selective tracer 11C-PD153035 in humans

1 reference

7 January 2021

In vivo evaluation of the biodistribution of 11C-labeled PD153035 in rats without and with neuroblastoma implants.

1 reference

7 January 2021

The HER family and cancer: emerging molecular mechanisms and therapeutic targets

1 reference

7 January 2021

Targeted therapies in breast cancer: where are we now?

1 reference

7 January 2021

HER2-targeted therapy in breast cancer. Monoclonal antibodies and tyrosine kinase inhibitors

1 reference

7 January 2021

Her2-positive breast cancer: herceptin and beyond.

1 reference

7 January 2021

Quantitative immuno-positron emission tomography imaging of HER2-positive tumor xenografts with an iodine-124 labeled anti-HER2 diabody

1 reference

7 January 2021

Optimizing radiolabeled engineered anti-p185HER2 antibody fragments for in vivo imaging

1 reference

7 January 2021

A new and convenient method for purification of 86Y using a Sr(II) selective resin and comparison of biodistribution of 86Y and 111In labeled Herceptin

1 reference

7 January 2021

Imaging the pharmacodynamics of HER2 degradation in response to Hsp90 inhibitors

1 reference

7 January 2021

Imaging of HER-2 overexpression in tumors for guiding therapy

1 reference

7 January 2021

On the selection of a tracer for PET imaging of HER2-expressing tumors: direct comparison of a 124I-labeled affibody molecule and trastuzumab in a murine xenograft model.

1 reference

7 January 2021

Small-animal PET imaging of human epidermal growth factor receptor type 2 expression with site-specific 18F-labeled protein scaffold molecules

1 reference

7 January 2021

In vivo near-infrared fluorescence imaging of integrin alphavbeta3 in brain tumor xenografts

1 reference

7 January 2021

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

1 reference

7 January 2021

Specific targeting of tumor angiogenesis by RGD-conjugated ultrasmall superparamagnetic iron oxide particles using a clinical 1.5-T magnetic resonance scanner.

1 reference

7 January 2021

Imaging tumor angiogenesis with contrast ultrasound and microbubbles targeted to alpha(v)beta3.

1 reference

7 January 2021

In vitro and in vivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3.

1 reference

7 January 2021

Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD

1 reference

7 January 2021

Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man.

1 reference

7 January 2021

[18F]galacto-RGD positron emission tomography for imaging of alphavbeta3 expression on the neovasculature in patients with squamous cell carcinoma of the head and neck

1 reference

7 January 2021

Patterns of alphavbeta3 expression in primary and metastatic human breast cancer as shown by 18F-Galacto-RGD PET.

1 reference

7 January 2021

Imaging of alpha(v)beta(3) expression by a bifunctional chimeric RGD peptide not cross-reacting with alpha(v)beta(5).

1 reference

7 January 2021

Phase I trial of the positron-emitting Arg-Gly-Asp (RGD) peptide radioligand 18F-AH111585 in breast cancer patients

1 reference

7 January 2021

MicroPET imaging of brain tumor angiogenesis with 18F-labeled PEGylated RGD peptide

1 reference

7 January 2021

In vivo imaging of apoptosis

1 reference

7 January 2021

MBP-annexin V radiolabeled directly with iodine-124 can be used to image apoptosis in vivo using PET.

1 reference

7 January 2021

Imaging apoptosis in vivo using 124I-annexin V and PET.

1 reference

7 January 2021

PET imaging of apoptosis with (64)Cu-labeled streptavidin following pretargeting of phosphatidylserine with biotinylated annexin-V.

1 reference

7 January 2021

Seeing death in the living

1 reference

7 January 2021

Phagocytosis of necrotic cells by macrophages is phosphatidylserine dependent and does not induce inflammatory cytokine production

1 reference

7 January 2021

Potent and selective nonpeptide inhibitors of caspases 3 and 7 inhibit apoptosis and maintain cell functionality

1 reference

7 January 2021

Positron emission tomography imaging of drug-induced tumor apoptosis with a caspase-3/7 specific [18F]-labeled isatin sulfonamide

1 reference

7 January 2021

[18F]- and [11C]-labeled N-benzyl-isatin sulfonamide analogues as PET tracers for apoptosis: synthesis, radiolabeling mechanism, and in vivo imaging study of apoptosis in Fas-treated mice using [11C]WC-98.

1 reference

7 January 2021

Characterization of membrane potential-dependent uptake of the novel PET tracer 18F-fluorobenzyl triphenylphosphonium cation

1 reference

7 January 2021

Molecular imaging of cell death in vivo by a novel small molecule probe

1 reference

7 January 2021

Synthesis, biological evaluation and radiochemical labeling of a dansylhydrazone derivative as a potential imaging agent for apoptosis

1 reference

7 January 2021

Molecular imaging of neurovascular cell death in experimental cerebral stroke by PET.

1 reference

7 January 2021

Imaging matrix metalloproteinases in cancer

1 reference

7 January 2021

Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor

1 reference

7 January 2021

Synthesis and preliminary biological evaluation of MMP inhibitor radiotracers [11C]methyl-halo-CGS 27023A analogs, new potential PET breast cancer imaging agents.

1 reference

7 January 2021

A new 18F-labelled derivative of the MMP inhibitor CGS 27023A for PET: radiosynthesis and initial small-animal PET studies

1 reference

7 January 2021

The urokinase receptor as an entertainer of signal transduction

1 reference

7 January 2021

Evolving role of uPA/uPAR system in human cancers

1 reference

7 January 2021

In vitro inhibition of human glioblastoma cell line invasiveness by antisense uPA receptor

1 reference

7 January 2021

Inhibition of Sp1 activity by a decoy PNA-DNA chimera prevents urokinase receptor expression and migration of breast cancer cells

1 reference

7 January 2021

Imaging of urokinase-type plasminogen activator receptor expression using a 64Cu-labeled linear peptide antagonist by microPET.

1 reference

7 January 2021

Expression of integrin alphavbeta3 in gliomas correlates with tumor grade and is not restricted to tumor vasculature

1 reference

7 January 2021

Expression of alpha(v)beta3 integrin is less frequent in ovarian epithelial tumors of low malignant potential in contrast to ovarian carcinomas

1 reference

7 January 2021

Integrin activation controls metastasis in human breast cancer

1 reference

7 January 2021

Activated integrin alphavbeta3 cooperates with metalloproteinase MMP-9 in regulating migration of metastatic breast cancer cells

1 reference

7 January 2021

Imaging of integrin alphavbeta3 expression

1 reference

7 January 2021

Chemokine receptors in cancer metastasis and cancer cell-derived chemokines in host immune response

1 reference

7 January 2021

64Cu-AMD3100--a novel imaging agent for targeting chemokine receptor CXCR4.

1 reference

7 January 2021

Recommendations on the use of 18F-FDG PET in oncology

1 reference

7 January 2021

Multimodality imaging: an update on PET/CT technology

1 reference

7 January 2021

Tumor cell metabolism imaging

1 reference

7 January 2021

Cancer's molecular sweet tooth and the Warburg effect.

1 reference

7 January 2021

Causes and consequences of increased glucose metabolism of cancers

1 reference

7 January 2021

Dual-modality imaging: combining anatomy and function

1 reference

7 January 2021

18F-FDG PET and PET/CT in the evaluation of cancer treatment response

1 reference

7 January 2021

PET/CT for therapy response assessment in lymphoma

1 reference

7 January 2021

Revised response criteria for malignant lymphoma

1 reference

7 January 2021

From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors

1 reference

7 January 2021

Role of 18F-FDG PET in assessment of response in non-small cell lung cancer

1 reference

7 January 2021

PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial

1 reference

7 January 2021

PET/MRI system design.

1 reference

7 January 2021

Latest advances in molecular imaging instrumentation

1 reference

7 January 2021

Identifiers

DOI

10.1002/CMMI.368

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:20812287%20AND%20SRC:MED&resulttype=core&format=json

13 February 2020

1 reference